Synthesis, Pharmacology, and Molecular Docking Studies on 6-Desoxo-N-methylmorphinans as Potent μ-Opioid Receptor Agonists-Reference-Cited by-同舟云学术

Synthesis, Pharmacology, and Molecular Docking Studies on 6-Desoxo-N-methylmorphinans as Potent μ-Opioid Receptor Agonists

Published:2017-11-03 Issue:22 Volume:60 Page:9407-9412
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Dumitrascuta Maria¹,Ben Haddou Tanila¹,Guerrieri Elena¹,Noha Stefan M.¹,Schläfer Lea¹,Schmidhammer Helmut¹,Spetea Mariana¹^ORCID

Affiliation:

1. Department of Pharmaceutical Chemistry, Institute of Pharmacy and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria

Funder

Austrian Science Fund

Tyrolean Research Fund

Swarovski Kristallwelten Wattens

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

http://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.7b01363

Reference44 articles.

1. Morphine: New aspects in the study of an ancient compound

2. Mu Opioids and Their Receptors: Evolution of a Concept

3. The µ Opioid Receptor and Ligands Acting at the µ Opioid Receptor, as Therapeutics and Potential Therapeutics

4. Re-energizing the Development of Pain Therapeutics in Light of the Opioid Epidemic

5. Time for nonaddictive relief of pain

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies for developing μ opioid receptor agonists with reduced adverse effects;Bioorganic Chemistry;2024-08

2. Recent Chemical and Pharmacological Developments on 14-Oxygenated-N-methylmorphinan-6-ones;Molecules;2021-09-18

3. New Small-molecule Analgesics;Current Medicinal Chemistry;2021-09-17

4. Predictive Models to Identify Small Molecule Activators and Inhibitors of Opioid Receptors;Journal of Chemical Information and Modeling;2021-05-28

5. Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands;The Kappa Opioid Receptor;2021